Previous studies have demonstrated that female gender and/or estrogens can be protective in experimental models of PAH, such as the hypoxic and monocrotaline models and mice lacking the vasoactive intestinal peptide gene [4,5,25]. This evidence concerns the gene VIP and pulmonary arterial hypertension.